Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria

Progeria

Phase I Study of Progerinin in Healthy Volunteers Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria Umbilical Cord Blood Transfusion in Progeria Syndrome Clinical Studies of Progeria Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria